Shanghai VKEY Biotechnologies Co.,Ltd. provides a wide range of cell-based screening services, including cAMP/IP1 detection, Kinase Target Engagement Assay, Phosphoprotein Detection assay, Protein-protein Interaction assay, and more. Our assays utilize advanced technologies such as TR-FRET, NanoBRET, Luminescent, and others.
PROTAC, a highly promising drug development technology, facilitates rapid degradation of target proteins by connecting them to E3 recruiting enzymes. Shanghai VKEY Biotechnologies Co.,Ltd. provides a comprehensive PROTAC drug screening solution, including services for screening properties like transmembrane capability and trimer complex formation of PROTAC molecules.